Related Experiment Video
Updated: Jun 6, 2025
12:23
In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
Published on: September 7, 2022
1.6K
Insights into SARS-CoV-2: Small-Molecule Hybrids for COVID-19 Treatment
Maria Luisa Navacchia1, Caterina Cinti1, Elena Marchesi2
1Institute for Organic Synthesis and Photoreactivity (ISOF), National Research Council of Italy (CNR), 40129 Bologna, Italy.
Molecules (Basel, Switzerland)
|November 27, 2024
Summary
Hybrid functional compounds, combining multiple therapeutic agents, show promise for treating COVID-19. This review covers small-molecule hybrids with potential antiviral activity against SARS-CoV-2.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Drug Discovery
Background:
- Combining therapeutic agents with distinct mechanisms offers advantages in treatment.
- Molecular hybridization covalently links pharmacophores, addressing challenges in drug development.
- This strategy is being explored for novel COVID-19 therapeutics.
Purpose of the Study:
- To review small-molecule hybrids with potential antiviral activity against SARS-CoV-2.
- To summarize existing literature on natural product and synthetic hybrids.
- To highlight the potential of molecular hybridization in combating COVID-19.
Main Methods:
- Literature review of scientific publications.
- Identification of small-molecule hybrids targeting SARS-CoV-2.
- Analysis of compounds from both natural and synthetic origins.
Main Results:
- Numerous small-molecule hybrids with reported anti-SARS-CoV-2 activity were identified.
- Compounds derived from both natural products and synthetic chemistry show promise.
- The review consolidates current knowledge on these hybrid antiviral agents.
Conclusions:
- Small-molecule hybrids represent a promising avenue for developing new antiviral drugs against SARS-CoV-2.
- Molecular hybridization offers a versatile approach for drug design.
- Further research into these hybrids could lead to effective COVID-19 treatments.
Keywords:
COVID-19SARS-CoV-2 Mproantiviral activitydrug designmolecular hybridizationnatural product hybridssmall moleculesMore Related Videos
Related Concept Videos
01:26Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
02:50Conjugated Proteins
18.2K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.2K